risperidone has been researched along with Benign Intracranial Hypertension in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 17-year-old girl gained more than 25 kg in weight during treatment with risperidone and subsequently developed headache, diplopia and loss of vision due to IIH." | 3.81 | [Idiopathic intracranial hypertension and obesity]. ( Braakman, HM; Naarden, MT; Porro, GL; Schuitemaker, A; Straver, JS; van Doormaal, TP, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naarden, MT | 1 |
| Schuitemaker, A | 1 |
| Braakman, HM | 1 |
| van Doormaal, TP | 1 |
| Porro, GL | 1 |
| Straver, JS | 1 |
| Ahmed, H | 1 |
| Ali, H | 1 |
2 other studies available for risperidone and Benign Intracranial Hypertension
| Article | Year |
|---|---|
[Idiopathic intracranial hypertension and obesity].
Topics: Adolescent; Antipsychotic Agents; Female; Headache; Humans; Obesity; Pseudotumor Cerebri; Risperidon | 2015 |
Risperidone induced weight gain leading to benign intracranial hypertension.
Topics: Antipsychotic Agents; Bipolar Disorder; Female; Humans; Obesity, Morbid; Pseudotumor Cerebri; Risper | 2011 |